Conclusions
Adenovirus-mediated HSVtk gene therapy has been shown to be eefective for the treatment of malignant glioma when the gene transfer efficiency is high. Adenoviruses are currently the most promising vectors for gene therapy of malignant glioma especially because of their high efficiency of gene transfer. Experiences from preclinical in vitro and in vivo studies are promising and in the near future the first reports of clinical phase I and II studies should be available. These results will significantly advance our understanding about the efficacy of adenovirus-mediated gene transfers in the treament of malignant glioma in man.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ammirati, M., Galicich, J.H., Arbit, E., and Liao, Y. 1987, Reoperation in the treatment of recurrent intracranial malignant gliomas. Neurosurgery 21:607–614.
Bi, W.L., Parysek, L.M., Warnick, R., and Stambrook, P.J., 1993, In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSVtk retroviral gene therapy. Hum. Gene Ther. 4:725–731.
Boviatsis, E.J., Chase, M., Wei, MX., Tamiya, T., Hurford, R.K.Jr., Kowall, N.W., Tepper, R.I., Breakefield, X.O., and Chiocca, E.A. 1994, Gene transfer into experimental brain tumors mediated by adenovirus, Herpes simplex virus, and retrovirus vectors. Hum Gene Ther 5:183–191.
Chen, S.-H., Shine, H.D., Goodman, J.C., Grossman, R.G., and Woo, S.L.C. 1994, Gene therapy for brain tumors: Regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc Natl Acad Sci USA 91:3054–3057.
Colak, A., Goodman, J.C., Chen, S.H., Woo, S.L.C., Grossman, R.G., and Shine, H.D., 1995, Adenovirus-mediated gene therapy for experimental spinal cord tumors: tumoricidal efficacy and functional outcome. Brain Research. 691:76–82.
Davies, E., Clarke, C., and Hopkins, A., 1996, Malignant cerebral glioma-1: Survival, disability, and morbidity after radiotherapy. BMJ, 313:1507–1512.
Dietrich, P.Y., Walker, P.R., Saas, P., and de Tribolet, N., 1997, Immunobiology of Gliomas: New Perspectives for Therapy, Ann NY Acad Sci 824:124–140.
Fuller, G.N., and Burger, P.C., 1996, Gliomas: Pathology, in: Neurosurgery. Volume 1 (Wilkins, R.H., and Rengachary, S.S., eds). pp. 735–747, McGrawn-Hill, Health professions Division.
Hildebrandt, J., Dewitte, O., Dietrich, P.Y., and de Tribolet, N., 1997, Eur Neurol, 38:238–253.
Kajiwara, K., Byrnes, A.P., Charlton, H.M., Wood, M.J.A., and Wood, K.J., 1997, Immune Responses to Adenoviral Vectors During Gene Transfer in the Brain. Hum. Gene Ther. 8:253–265.
Kaneko, Y., Kitamoto, T., Tateishi, J., and Yamaguchi, K. 1989, Ferritin immunohistochemistry as a marker for microglia. Acta Neuropathol, 79:129–136.
Kernohan, J.W., Mabon, R.F., Svien, H.J., and Adson, A.W., 1949, A simplified classification of the gliomas. Proc Staff Mtg Mayo Clin, 24:71–75.
Kleilhues, P., Burger, P.C., and Scheithauer, B.W., 1993, The new WHO classification of brain tumours. Brain Pathol, 3:255–268.
Laitinen, M., Mäkinen, K., Manninen, H., Matsi, P., Kossila, M., Agrawal, R.S., Pakkanen, T., Luoma, J.S., Viita, H., Hartikainen, J., Alhava, E., Laakso, M., and Ylä-Herttuala, S., 1998, Adenovirus-mediated gene transfer to lower limb artery of patients with chronic critical leg ischaemia. Hum Gene Ther, 9:1481–1486.
Le Gal La Salle, G., Robert, J.J., Berrard, V, Ridoux. L.D., Stratford-Perricaudet, L.D., Perricaudet, M., and Mallet, J., 1993, An adenovirus vector for gene transfer into neurons and glia in the brain. Science 259:988–990.
Leibel, S.A., Gutin, P.H., Wara, W.M., Silver, P.S., Larson, D.A., Edwards, M.S., Lamb, S.A., Ham. B., Weaver, K.A., and Barnett, C., 1989, Survival and quality of life after interstitial implantation of removable high-activity iodine-125 sources for the treatment of patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys, 17:1129–1139.
Levy, M.L., and Apuzzo, M.L.J., Immunobiolgy of Brain Tumors, in: Neurosurgery, Volume 1 (Wilkins, R.H., and Rengachary, S.S., eds), pp. 707–713, McGrawn-Hill, Health professions Division.
Maron, A., Havaux, N., Le Roux, A., Knoops, B., Perricaudet, M., and Octave, J.N., 1997, Differential toxicity of ganciclovir for rat neurons and astrocytes in primary culture following adenovirus-mediated transfer of the HSVtk gene. Gene Ther. 4:25–31.
Maron, A., Le Roux, A.L., Mottet, I., Dedieu, J.F., Brion, J.P., Demeure, R., Perricaudet, M., and Octave, J.N., 1996, Gene therapy of rat C6 glioma using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene: long-term follow-up by magnetic resonance imaging. Gene Therapy. 3:315–322.
Moolten, F.L., 1994, Drug sensitivity (“suicide”) genes for selective cancer chemotherapy. Cancer Gene Ther, 1:279–287.
Perez-Cruet, M.J., Trask, T.W., Chen, S.H., Goodman, J.C., Woo, S.L.C., Grossman, R.G., and Shine, H.D., 1994, Adenovirus-Mediated Gene Therapy of Experimental Gliomas. Journal of Neuroscience Research. 39:506–511.
Puumalainen, A.M., Puranen, P., Loimas, S., Puranen, M., Hurskainen, H., Kossila, M., Tyynelä, K., Turunen, M., Vanninen, R., Lehtolainen, P., Paljärvi, L., Johansson, R., Vapalahti, M., and Ylä-Herttuala, S. Thymidine kinase gene therapy for human malignant glioma using replication-deficient retroviruses or adenoviruses. Phase I safety and efficacy trial. Submitted.
Puumalainen, A.M., Turunen, M., Loimas, S., Vainio, P., Tyynelä, K.., Vanninen, R., Vapalahti, M., Bjerkvig, R., Jänne, J., and Ylä-Herttuala, S., Herpes Simplex virus thymidine kinase gene therapy in experimental rat BT4C glioma model. Submitted.
Puumalainen, A.M., Vapalahti, M., Agrawal, R., Kossila, M., Laukkanen, M., Lehtolainen, P., Viita, H., Paljärvi, L., Vanninen, R., and Ylä-Herttuala, S., 1998, B-galactosidase gene transfer to human malignant glioma in vivo using replication-deficientretroviruses and adenoviruses. Hum. Gene Ther. 9:1769–1774.
Ram, Z., Culver, K.W., Oshiro, E.M., Viola, J.J., DeVroom, H.L., Otto, E., Long, Z., Chiang, Y., McCarrity, G.J., Muul, L.M., Katz, D., Blaese, M., and Oldfield, E.H., 1997, Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells. Nature Medicine 3:1354–1361.
Salcman, M., 1980, Survival in glioblastoma. Historical prespective. Neurosurgery, 7:435–439.
Salcman, M., 1996, Supratentorial Gliomas: Clinical Features and Surgical Therapy, in: Neurosurgery, Volume 1 (Wilkins, R.H., and Rengachary, S.S., eds), pp. 777–788, McGrawn-Hill, Health professions Division.
Tyynelä, K., Puumalainen, A.M., Turunen, M., Hakumäki, J., Kauppinen, R., Johansson, R., and Ylä-Herttuala, S., 1998, Adenovirus-mediated Herpes simplex virus-thymidine kinase gene therapy in BT4C rat glioma in vivo. Submitted.
Vincent, A.J.P.E., Esandi, M.C., Avezaat, C.J.J., Vecht, C, Smitt, P.S., Bekkum, D.W., Valerio, D., Hoogerbrugge, P.M., and Bout, A., 1997, Preclinical Testing of Recombinant Adenoviral Herpes Simplex Virus-Thymidine Kinase Gene Therapy for Central Nervous System Malignancies. Neurosurgery. 41:442–452.
Vincent, A.J.P.E., Esandi, M.C., Someren, G., Notebloom, J.L., Avezaat, C.J.J., Vecht, C., Smitt, P.A.E.S., Bekkum, D.W., Valerio, D., Hoogerbrugge, P.M., and Bout, A., 1996, Treatment of leptomeningeal metastases in a rat model using a recombinant adenovirus containing the HSV-tk gene. J Neurosurg. 85:648–654.
Vincent, A.J.P.E., Vogels, R., Someren, G.V., Esandi, M.C., Notebloom, J.L., Avezaat, C.J.J., Vecht, C., Bekkum, D.W.V., Valerio, D., Bout, A., and Hoogerbrugge, P.M., 1996, Herpes Simplex Virus Thymidine Kinase Gene Therapy for Rat Malignant Brain Tumors. Human Gene Therapy. 7:197–205.
Viola, J.J., Ram, Z., Walbridge, S., Oshiro, E.M., Trapnell, B., Tao-Cheng, J.H., and Oldfield, E.H., Adenovirally mediated gene transfer into experimental solid brain tumors and leptomeningeal cancer cells. J Neurosurg 82:pp70–76.
Walker, M.D., Alexander, E., Hunt, W.E., MacCarty, C.S., Mahaley, J., and Norell, H.A., et al., 1978, J Neurosurg, 49:333–343.
Walker, M.D., Green, S.B., Byar, D.P., Alexander, E., Batzdorf, U., Brooks, W.H., Hunt, WE., MacCarty, C.S., Mahaley, M.S., Mealey, J., Owens, G., Ransohoff, J., Robertson, J.T., Saphiro, W.R., Smith, K.R. Jr., Wilson, C.B., and Strike, T.A., 1980, Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med, 303:1323–1329.
Watkins, D., and Rouleau, G.A., 1994, Genetics, Prognosis and Therapy of Central Nervous System Tumors. Cancer Detection and Prevention, 18:139–144.
Wilson, J., 1995, Adenoviruses as Gene-Delivery Vehicles. N Engl J Med 334:1185–1187.
Ylä-Herttuala, S., 1998, Gene therapy for cancer. In: Tumor Invasion: Biological, Clinical and Therapeutical Considerations. (Mikkelsen, Bjerkvig, Laerum, Rosenblum eds), pp. 435–445, John Wiley & Sons.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic Publishers
About this chapter
Cite this chapter
Sandmair, AM., Vapalahti, M., Ylä-Herttuala, S. (2002). Adenovirus-Mediated Herpes Simplex Thymidine Kinase Gene Therapy For Brain Tumors. In: Habib, N.A. (eds) Cancer Gene Therapy. Advances in Experimental Medicine and Biology, vol 465. Springer, New York, NY. https://doi.org/10.1007/0-306-46817-4_15
Download citation
DOI: https://doi.org/10.1007/0-306-46817-4_15
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-306-46191-0
Online ISBN: 978-0-306-46817-9
eBook Packages: Springer Book Archive